A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

Saphenous Vein Graft Disease Clinical Trial

Official title:
Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis

Status Completed

Clinical Trial Summary

A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Clinical Trial Description

To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease. ;

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

Saphenous Vein Graft Disease

Clinical Trial Details

NCT number	NCT01036048
Study type	Observational
Source	Catholic University of the Sacred Heart
Contact
Status	Completed
Phase	N/A
Start date	May 2009
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02053909` - Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis	Phase 4
Completed	`NCT00263263` - RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.	Phase 2
Recruiting	`NCT03175952` - Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.	N/A
Completed	`NCT01528709` - Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)	Phase 3
Completed	`NCT00453518` - The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts	N/A
Terminated	`NCT00264706` - PolyArginine Treated vEiN grafTs (PATENT)	Phase 1/Phase 2
Terminated	`NCT01042444` - Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft	N/A